Porcine endogenous retrovirus envelope coated baculoviral DNA vaccine against porcine reproductive and respiratory syndrome virus. Issue 1 (2nd January 2020)

• Record Type: Journal Article
• Authors: Cho, Yeondong; Heo, Yoonki; Choi, Hanul; Park, Ki Hoon; Kim, Sehyun; Jang, Yuyeon; Lee, Hee-Jung; Kim, Minji; Kim, Young Bong
• Is Part Of: Animal biotechnology. Volume 31:Issue 1(2020)
• Page Start: 32
• Page End: 41
• Publication Date: 2020-01-02
• Subjects: Endogenous retrovirus -- baculovirus -- vaccines -- PRRSV; Animal biotechnology -- Periodicals; Animals, Domestic -- genetics -- Periodicals; Animals, Genetically Modified -- Periodicals; 660.6
• DOI: 10.1080/10495398.2018.1531014
• Languages: English
• ISSNs: 1049-5398

Abstract

Abstract: PERV is a major virus concerning xenotransplantation study. However, the interesting part is that PERV is present in all kinds of pigs without pathogenicity and immune response. Furthermore, since pig cells have receptors for PERV, the gene delivery system using PERV envelope is highly likely to develop into an excellent viral vector in pigs. We developed a recombinant baculovirus with a modified surface for expressing the porcine endogenous retrovirus (PERV) envelope. Porcine reproductive and respiratory syndrome virus (PRRSV) infection is a severe concern in the porcine industry due to reproduction failure and respiratory symptoms. GP5 and M proteins are major immunogenic proteins of PRRSV. Using PERV-modified baculovirus (Ac mPERV) as a delivery vector, we constructed a dual antigen (GP5 and M)-encoding DNA vaccine system, Ac mPERV-C5/C6. Intramuscular immunization in mice and pigs, Ac mPERV-C5/C6 induced comparative high humoral and cellular immune responses. Our results support further development of Ac mPERV-C5/C6 as a potential PRRSV vaccine in the porcine industry. In addition, the Ac mPERV system may be applied to the generation of other effective DNA vaccines against porcine viral diseases.